Hesperidin exerts antidepressant-like effects in acute and chronic treatments in mice: Possible role of l-arginine-NO-cGMP pathway and BDNF levels

Brain Research Bulletin

Volumn 104, Issue , 2014, Pages 19-26

  Donato, Franciele ^a   de Gomes, Marcelo Gomes ^a   Goes, André Tiago Rossito ^a   Filho, Carlos Borges ^a   Del Fabbro, Lucian ^a   Antunes, Michelle S ^a   Souza, Leandro Cattelan ^a   Boeira, Silvana Peterini ^a   Jesse, Cristiano Ricardo ^a  

^a UNIVERSIDADE FEDERAL DO PAMPA   (Brazil)

Author keywords

Brain diseases; Depression; Flavonoid; Mechanisms; Neurotrophic factors

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 7 NITROINDAZOLE; ARGININE; BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLIC GMP; FLUOXETINE; HESPERETIN; HESPERIDIN; IMIPRAMINE; METHYLENE BLUE; N ACETYL S NITROSOPENICILLAMINE; N(G) NITROARGININE; NITRATE; NITRITE; SILDENAFIL; ANTIDEPRESSANT AGENT; NITRIC OXIDE;

ACUTE DRUG ADMINISTRATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIDEPRESSANT ACTIVITY; ARTICLE; BRAIN LEVEL; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DOSE RESPONSE; EMERGENCY CARE; EX VIVO STUDY; HIPPOCAMPUS; IMMOBILITY; LOCOMOTION; LONG TERM CARE; MALE; MOUSE; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TAIL SUSPENSION TEST; ANIMAL; DRUG EFFECTS; METABOLISM; MOTOR ACTIVITY;

ANIMALS; ANTIDEPRESSIVE AGENTS; ARGININE; BRAIN-DERIVED NEUROTROPHIC FACTOR; CYCLIC GMP; HESPERIDIN; HIPPOCAMPUS; MALE; MICE; MOTOR ACTIVITY; NITRIC OXIDE; SIGNAL TRANSDUCTION;

EID: 84898954223     PISSN: 03619230     EISSN: 18732747     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2014.03.004     Document Type: Article

References (45)

1. Ahmad S.T., Arjumand W., Nafees S., Seth A., Ali N., Rashid S., Sultana S. Hesperidin alleviates acetaminophen induced toxicity in Wistar rats by abrogation of oxidative stress, apopotosis and inflammation. Toxicol. Lett. 2012, 205:149-161.
2. Almeida R.C., Felisbino C.S., López M.G., Rodrigues A.L.S., Gabilan N.H. Evidence for the involvement of l-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of memantine in mice. Behav. Brain Res. 2006, 168:318-322.
3. Banasr M., Dwyer J.M., Duman R.S. Cell atrophy and loss in depression: reversal by antidepressant treatment. Curr. Opin. Cell Biol. 2011, 23:730-737.
4. Baranano D.E., Ferris C.D., Snyder S.H. A typical neural messengers. Trends Neurosci. 2001, 24:99-106.
5. Chrapko W., Jurasz P., Radomski M.W., Archer S.L., Newman S.C., Baker G., Lara N., Le Mellédo J.M. Alteration of decreased plasma NO metabolites and platelet NO synthase activity by paroxetine in depressed patients. Neuropsychopharmacology 2006, 31:1286-1293.
6. Cryan J.F., Mombereau C., Vassout A. The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neuroci. Biobehav. Rev. 2005, 29:571-625.
7. Da Silva G.D., Matteussi A.S., Santos A.R.S., Calixto J.B., Rodrigues A.L.S. Evidence for dual effects of nitric oxide in the forced swimming test and in the tail suspension test in mice. Neuroreport 2000, 11:3699-3702.
8. Dhir A., Kulkarni S.K. Involvement of l-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of venlafaxine in mice. Prog. Neuropsychopharmacol. Biol. Psychiatry 2007, 31:921-925.
9. Fernández S.P., Wasowski C., Paladini A.C., Marder M. Synergistic interaction between hesperidin, a natural flavonoid, and diazepam. Eur. J. Pharmacol. 2005, 512:189-198.
10. Filho C.B., Del Fabbro L., de Gomes M.G., Goes A.T.R., Souza L.C., Boeira S.P., Jesse C.R. Kappa-opioid receptors mediate the antidepressant-like activity of hesperidin in the mouse forced swimming test. Eur. J. Pharmacol. 2013, 698:286-291.
11. First M., Gil-Ad I., Taler M., Tarasenko I., Novak N., Weizman A. The effects of fluoxetine treatment in a chronic mild stress rat model on depression-related behavior, brain neurotrophins and ERK expression. J. Mol. Neurosci. 2011, 45:246-255.
12. Gałecki P., Maes M., Florkowski A., Lewiński A., Gałecka E., Bieńkiewicz M., Szemraj J. An inducible nitric oxide synthase polymorphism is associated with the risk of recurrent depressive disorder. Neurosci. Lett. 2010, 486:184-187.
13. Ghasemi M., Sadeghipour H., Poorheidari G., Dehpour A.R. A role for nitrergic system in the antidepressant-like effects of chronic lithium treatment in the mouse forced swimming test. Behav. Brain Res. 2009, 200:76-82.
14. Gonul A.S., Akdeniz F., Taneli F., Donat O., Eker C., Vahip S. Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients. Eur. Arch. Psychiatry Clin. Neurosci. 2005, 255:381-386.
15. Harkin A., Bruce K.H., Craft B., Paul I.A. Nitric oxide synthase inhibitors have antidepressant-like properties in mice, 1. Acute treatments are active in the forced swim test. Eur. J. Pharmacol. 1999, 372:207-213.
16. Harkin A.J., Connor T.J., Burns M.P., Kelly J.P. Nitric oxide synthase inhibitors augment the effects of serotonin reuptake inhibitors in the forced swimming test. Eur. Neuropsychopharmacol. 2004, 14:274-281.
17. Heiberg I.L., Wegener G., Rosenberg R. Reduction of cGMP and nitric oxide has antidepressant-like effects in the forced swimming test in rats. Behav. Brain Res. 2002, 134:479-484.
18. 2-induced cytotoxicity in PC12 cells. J. Agric. Food Chem. 2008, 56:859-864.
19. Ikemura M., Sasaki Y., Giddings J.C., Yamamoto J. Preventive effects of hesperidin, glucosyl hesperidin and naringin on hypertension and cerebral thrombosis in stroke-prone spontaneously hypertensive rats. Phytother. Res. 2012, 26:1272-1277.
20. Jesse C.R., Bortolatto C.F., Savegnago L., Rocha J.B., Nogueira C.W. Involvement of l-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of tramadol in the rat forced swimming test. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32:1838-1843.
21. Jesse C.R., Wilhelm E.A., Bortolatto C.F., Rocha J.B., Nogueira C.W. Involvement of l-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of bis selenide in the mouse tail suspension test. Eur. J. Pharmacol. 2010, 635:135-141.
22. Jin Y., Fischer I., Tessler A., Joule J.D. Transplants of fibroblasts genetically modified to express BDNF promote axonal regeneration from supraspinal neurons following chronic spinal cord injury. Exp. Neurol. 2002, 1:265-275.
23. Kaster M.P., Rosa A., Santos A.R.S., Rodrigues A.L.S. Involvement of nitric oxide-cGMP pathway in the antidepressant-like effects of adenosine in the forced swimming test. Int. J. Neuropsychopharmacol. 2005, 8:601-606.
24. 1A receptors in the antidepressant-like effect of adenosine in the mouse forced swimming test. Brain Res. Bull. 2005, 67:53-61.
25. Kiecolt-Glaser J.K., Glaser R. Depression and immune function: central pathways to morbidity and mortality. J. Psychosom. Res. 2002, 53:873-876.
26. Krass M., Wegener G., Vasar E., Volke V. The antidepressant action of imipramine and venlafaxine involves suppression of nitric oxide synthesis. Behav. Brain Res. 2011, 218:57-63.
27. Kulkarni S.K., Dhir A. Possible involvement of l-arginine-nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) signaling pathway in the antidepressant activity of berberine chloride. Eur. J. Pharmacol. 2007, 569:77-83.
28. Kumar P., Kumar A. Protective effect of hesperidin and naringin against 3-nitropropionic acid induced Huntington's like symptoms in rats: possible role of nitric oxide. Behav. Brain Res. 2010, 206:38-46.
29. Lee K.H., Yeh M.H., Kao S.T., Hung C.M., Yeh C.C. The inhibitory effect of hesperidin on tumor cell invasiveness occurs via suppression of activator protein 1 and nuclear factor-kB in human hepatocellular carcinoma cells. Toxicol. Lett. 2010, 194:42-49.
30. Miranda K.M., Espey M.G., Wink D.A. A rapid, simple spectrophotometricmethod for simultaneous detection of nitrate and nitrite. Nitric Oxide 2001, 5:62-71.
31. Peterson G.L. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal. Biochem. 1977, 83:346-356.
32. Réus G.Z., Stringari R.B., Kirsch T.R., Fries G.R., Kapczinski F., Roesler R., Quevedo J. Neurochemical and behavioural effects of acute and chronic memantine administration in rats: further support for NMDA as a new pharmacological target for the treatment of depression?. Brain Res. Bull. 2010, 81:585-589.
33. Raza S.S., Khan M.M., Ahmad A., Ashafaq M., Khuwaja G., Tabassum R., Javed H., Siddiqui M.S., Safhi M.M., Islam F. Hesperidin ameliorates functional and histological outcome and reduces neuroinflammation in experimental stroke. Brain Res. 2011, 1420:93-105.
34. Schmidt H.D., Duman R.S. The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior. Behav. Pharmacol. 2007, 18:391-418.
35. Smith J.C., Whitton P.S. Nitric oxide modulates N-methyl-daspartate-evoked serotonin release in the raphe nuclei and frontal cortex of the freely moving rat. Neurosci. Lett. 2000, 291:5-8.
36. Schuman E.M., Madison D.V. Nitric oxide and synaptic function. Annu. Rev. Neurosci. 1994, 17:153-183.
37. Sem S., Duman R., Sanacora G. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol. Psychiatry 2008, 64:527-532.
38. Souza L.C., de Gomes M.G., Goes A.T.R., Del Fabbro L., Filho C.B., Boeira S.P., Jesse C.R. Evidence for the involvement of the serotonergic 5-HT1A receptors in the antidepressant-like effect caused by hesperidin in mice. Prog. Neuropsychopharmacol. Biol. Psychiatry 2013, 40:103-109.
39. Steru L., Chermat R., Thierry B., Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 1985, 85:367-370.
40. Volke V., Wegener G., Bourin M., Vasar E. Antidepressant- and anxiolytic-like effects of selective neuronal NOS inhibitor 1-(2-trifluoromethylphenyl)-imidazole in mice. Behav. Brain Res. 2003, 140:141-147.
41. Wiley J.L., Cristello A.F., Balster R.L. Effects of site-selective NMDA receptor antagonists in an elevated plus-maze model of anxiety in mice. Eur. J. Pharmacol. 1995, 294:101-107.
42. Yang H.L., Chen S.C., Kumar K.J.S., Yu K.N., Chao D.L., Tsai S.Y., Hou Y.C., Hse Y.C. Antioxidant and anti-inflammatory potential of hesperetin metabolites obtained from Hesperitin-administered rat serum: Na ex vivo approach. J. Agric. Food Chem. 2012, 60:522-532.
43. Yildiz F., Erden B.F., Ulak G., Utkan T., Gacar N. Antidepressant-like effect of 7-nitroindazole in the forced swimming test in rats. Psychopharmacology 2000, 149:41-44.
44. Yildiz F., Ulak G., Erden B.F., Gacar N. Anxiolytic-like effects of 7-nitroindazole in the rat plus-maze test. Pharmacol. Biochem. Behav. 2000, 65:199-202.
45. Yu H., Chen Z.Y. The role of BDNF in depression on the basis of its location in the neural circuitry. Acta Pharmacol. Sin. 2011, 32:3-11.